|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Short term investments | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Long term investments | ||||||||||||||||||||
| Software development costs, net of accumulated amortization | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Contingent liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Finance obligation, less current portion | ||||||||||||||||||||
| Deferred purchase price, less current portion | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies (Note 7) | ||||||||||||||||||||
| Preferred stock, shares outstanding | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock; $0.0001 par value; $10,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, shares outstanding (shares) | ||||||||||||||||||||
| Common stock, par value (per share) | ||||||||||||||||||||
| Common stock, shares authorized (shares) | ||||||||||||||||||||
| Common stock; $0.0001 par value; $50,000,000 shares authorized; shares issued: $18,440,358 and $18,150,878, respectively, shares outstanding: $17,416,286 and $17,261,755, respectively. | ||||||||||||||||||||
| Treasury stock at cost: 1,024,072 and 889,123 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Preferred stock, par value (per share) | ||||||||||||||||||||
| Preferred stock, shares authorized (shares) | ||||||||||||||||||||
| Preferred stock, shares issued | ||||||||||||||||||||
| Common stock, shares, issued (shares) | ||||||||||||||||||||
Loading...
